Volume 35 Number 6 August 5-13, 2015
Reviews, News and Commentaries
Target validation: Genetic information adds supporting weight.
Cully M et al. Nat Rev Drug Discov 2015 Jul 31. 14(8) 525
Cully M et al. Nat Rev Drug Discov 2015 Jul 31. 14(8) 525
Where next for genetics and genomics?
Tyler-Smith C, et al. PLoS Biol. 2015 Jul 30;13(7):e1002216.
Tyler-Smith C, et al. PLoS Biol. 2015 Jul 30;13(7):e1002216.
I am so very, very lucky! The FH Foundation, Aug 4
With insurers reluctant to pay for genomic testing, some patients turning to crowdfunding,Genome Web, Aug 4 [by free subscription only]
Genome analysis stratifies prostate cancers, by Rebecca Bazeley, PHG Foundation, Jul 31
PCR makes the jump to light speed, GEN, Jul 31
Understanding the function of cancer risk variants: Challenges and opportunities, by Sharna Tingle and Stefanie Nelson, Cancer Epidemiology Matters Blog, NCI, Jul 31
Do all BRCA mutations come with the same cancer risk? Dana-Farber Cancer Institute, Jul 30
Five subtypes of prostate cancer identified, paving way for more personalized treatments, by Ariana Eunjung Cha, The Washington Post, Jul 30
Gene-disease association data could improve drug development, by Brenda Iglesias, NHGRI, Jul 30
How can precision medicine help children with cancer? By Srivani Ravoori, Cancer Research Catalyst Blog, Jul 29
No hay comentarios:
Publicar un comentario